Aug 30, 2012 | Allgemein, company news @en, DE, new products
US pharmaceutical company Johnson & Johnson has acquired the licenses to a monoclonal antibody that is to be used, among other things, to combat bone marrow cancer. As part of this movement, the company has acquired a 10% stake in Danish biotechnology firm Genmab....
Aug 30, 2012 | Allgemein, company news @en, DE, new products
Those insured by private health insurance companies Axa and Gotha can expect a new service: those prescribed drugs from their doctor, or who regularly receive various prescription drugs from multiple physicians can use a drug check to protect themselves, as opposed...
Aug 30, 2012 | Allgemein, company news @en, DE, new products
For patients suffering from COPD (a combination of various lung diseases), the prospect of a more effective and non-injurious drug from the pharmaceutical company Novartis has been created. They indicated that the lung drug QVA149 had proven itself in the latest...
Aug 27, 2012 | Allgemein, company news @en, DE, new products
Alzheimer’s is still a very bad disease that is as of yet untreatable. In light of this, pharmaceutical company Eli Lilly and Company is the first to change this slightly. The initial results from two double-blind, placebo-controlled phase III studies with the...
Aug 20, 2012 | Allgemein, DE, new products
German health insurers DKV are to restructure their business from around early 2013, when they will no longer enter into „group insurance“ contracts. Whilst this division generated around 20% of their previous sales, too many of these contracts were no...
Mrz 16, 2012 | Allgemein, company news @en, DE, new products
The Frankfurt pharmaceutical wholesaler Andreae-Noris Zahn AG (Anzag) has included medical products by the British brand Alvita in its range of goods. The line comprises mainly diagnostic products like blood pressure measuring instruments, thermometers and pregnancy...
